Directly after acute ischemic stroke, tissue plasminogen activator (tPA) is used for thrombolysis, but beyond a few hours‐long time window of therapeutic opportunity, tPA treatment is associated with intracerebral hemorrhage, a consequence of induced BBB breakdown. The gene discussed is PLAT; the disease is intracerebral hemorrhage.